Biotechnology and new therapies for arthritis
Dibner, M.D.; Ackerman, N.R.
Journal of Rheumatology 13(6): 997-999
1986
ISSN/ISBN: 0315-162X PMID: 3560116 Document Number: 277466
Document emailed within 1 workday
Related Documents
Emery, P. 2001: Overview of current therapies for rheumatoid arthritis Journal of Rheumatology. Suppl 62: 1-3Weinblatt, M.E.; Maier, A.L. 1990: Newer immunosuppressive therapies for rheumatoid arthritis Critical Care Medicine 18(2 Suppl): S126-S131
Mortel, M.R.; Emer, J. 2010: Prospective new biologic therapies for psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 9(8): 947-958
Keystone, E.C. 2004: Safety issues related to emerging therapies for rheumatoid arthritis Clinical and Experimental Rheumatology 22(5 Suppl 35: S148-S150
Pincus, T.; Sokka, T.; Kavanaugh, A. 2004: Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard care Clinical and Experimental Rheumatology 22(5 Suppl. 35): S26-S33
Maini, R.N.; Wolfe, F. 1999: Workshop summary: health outcomes and health economic issues surrounding the use of biological therapies in patients with rheumatoid arthritis Rheumatology 38 Suppl. 2: 48-49
Gotoh, M. 2009: Treatment and rehabilitation programs for young alcoholics: acquiring the ability through group therapies and cognitive-behavioral therapies to communicate with others to lead a new life Nihon Arukoru Yakubutsu Igakkai Zasshi 44(5): 579-603
Campbell, R.K.; Cobble, M.E.; Reid, T.S.; Shomali, M.E. 2010: Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies Journal of Family Practice 59(9 Suppl 1: S20-S27
Tak, P.P. 2011: Are we ready to change the pace of arthritis treatment? Treating pre-arthritis and very early arthritis Acta Reumatologica Portuguesa 36(1): 8-9
Mazza, P. 1993: Pharmaceutical biotechnology Bollettino Chimico Farmaceutico 132(7): 247-251
Kannegiesser, H. 1990: Educating the public about biotechnology Australian Journal of Biotechnology 4(1): 14 17
Reiss, T. 2001: The European biotechnology funding map Mededelingen 66(3a): 3-10
Grunert, E. 1988: The role of endocrinology in biotechnology Deutsche Tierärztliche Wochenschrift 95(9): 388-391
Pollice, L. 1996: New biotechnology frontiers in histocytopathology Recenti Progressi in Medicina 87(11): 549-554
Rossomando, E.F. 2003: Business success in the biotechnology era Compendium of Continuing Education in Dentistry 24(10): 774; 777 779 Passim
Gulino, A. 1999: Biotechnology and molecular diagnostics Forum 9(3 Suppl 3: 37-46
Folstad, Tørn.; Magelssen, M.; Heen, E. 2007: New biotechnology legislation--only a milestone on the way? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(2): 205
Carnevale, A. 1995: Development of biotechnology in genetics Gaceta Medica de Mexico 131(4): 437-442
1992: Biotechnology. Entrepreneurs look for customers Nature 355(6359): 390
Calcott, P.H. 1992: Biotechnology product is safe American Pharmacy 32(2): 6